Healthcare Wrap: Bioxyne spikes, PainChek slides, FDA wins keep drawing buyers

• Bioxyne (ASX:BXN) led the sector after reporting a big half-year profit and revenue jump
• PainChek (ASX:PCK) and Vitura Health (ASX:VIT) fell hard as losses and margin pressure weighed
• FDA clearances and reimbursement updates remained a clear driver for imaging and diagnostics names
• Large capital raisings kept coming, signalling companies still need cash to reach commercial scale